SAB Biotherapeutics Market Sentiment

SPY777.95−0.02%QQQ743.58−0.33%BTC/USD83,235.70+1.83%DIA516.00−0.37%GLD381.40−0.20%TLT78.31+0.33%

Premium

SAB Biotherapeutics Inc

SABSNASDAQ

Trade with Public

$2.68

-0.15-5.3%

Last update: Oct 13, 3:59 PM

$2.93

0.103.53%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

SAB Biotherapeutics Market Sentiment

Market sentiment signals for SAB Biotherapeutics (SABS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 4.9% short float

Options Flow▼ 2.22 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

2.22

More puts — Bearish

45 calls · 100 puts

Avg Consensus PT

$11

+303.7%

Highest Price Target

$16

+494.8%

Chardan Capital

Lowest Price Target

+123.0%

HC Wainwright & Co.

Short Interest

4.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jun 24, 2026	Barclays	Eliana Merle—	+383.3%	$13	Initiate	Overweight
Jun 17, 2026	Chardan Capital	Keay Nakae—	+494.8%	$14 → $16	Maintained	Buy
Jun 15, 2026	Leerink Partners	Thomas Smith—	+346.1%	$7 → $12	Maintained	Outperform
Jun 15, 2026	HC Wainwright & Co.	Emily Bodnar—	+271.7%	$10 → $10	Maintained	Buy
May 22, 2026	Citigroup	Samantha Semenkow—	+308.9%	$11	Initiate	Buy
May 20, 2026	Jefferies	Roger Song—	+308.9%	$11	Initiate	Buy
May 12, 2026	HC Wainwright & Co.	Emily Bodnar—	+271.7%	$7 → $10	Maintained	Buy
May 11, 2026	Rodman & Renshaw	Seema Sheoran—	+383.3%	$13 → $13	Maintained	Buy
Apr 2, 2026	Rodman & Renshaw	Seema Sheoran—	+383.3%	$13	Initiate	Buy
Mar 11, 2026	Chardan Capital	Keay Nakae—	+420.4%	$12 → $14	Maintained	Buy
Mar 10, 2026	HC Wainwright & Co.	Emily Bodnar—	+160.2%	$9 → $7	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+160.2%	$7	Initiate	Buy
Dec 19, 2025	Guggenheim	Yatin Suneja—	+457.6%	$15	Initiate	Buy
Dec 18, 2025	Chardan Capital	Keay Nakae—	+346.1%	$12 → $12	Maintained	Buy
Nov 17, 2025	Chardan Capital	Keay Nakae—	+346.1%	$12 → $12	Maintained	Buy
Sep 19, 2025	Chardan Capital	Keay Nakae—	+346.1%	$12 → $12	Maintained	Buy
Sep 17, 2025	Leerink Partners	——	+160.2%	$7	Initiate	Outperform
Aug 8, 2025	Chardan Capital	Keay Nakae—	+346.1%	$20 → $12	Maintained	Buy
Jul 22, 2025	HC Wainwright & Co.	Emily Bodnar—	+234.6%	$10 → $9	Maintained	Buy
May 15, 2025	Chardan Capital	Keay Nakae—	+643.5%	$20 → $20	Maintained	Buy
May 14, 2025	HC Wainwright & Co.	Emily Bodnar—	+271.7%	$10	Assumes	Buy
Apr 1, 2025	Chardan Capital	Keay Nakae—	+643.5%	$25 → $20	Maintained	Buy
Apr 1, 2025	HC Wainwright & Co.	Edward White—	+123.0%	$6 → $6	Maintained	Buy
Jan 29, 2025	Chardan Capital	Keay Nakae—	+829.4%	$25 → $25	Maintained	Buy
Jan 29, 2025	HC Wainwright & Co.	Edward White—	+123.0%	$6 → $6	Maintained	Buy